Neuroimaging Biomarkers of Cancer Therapy-Related CNS Complications
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: 31 May 2026 | Viewed by 12
Special Issue Editor
Interests: magnetic resonance imaging; magnetic resonance spectroscopy; functional magnetic resonance imaging; diffusion tensor imaging; chemotherapy-induced cognitive impairment; immune-related adverse neurologic complications
Special Issue Information
Dear Colleagues,
The evolution and expanding use of targeted cancer therapies have been accompanied by the emergence of a variety of therapy-related neurotoxicities. This Special Issue aims to highlight the neurologic and psychological complications associated with neurotoxicity induced by chemotherapy, radiation therapy, and immune or biologic therapies. Of particular interest are neurologic immune-related adverse events, immune effector cell-associated neurotoxicity syndrome, and tumor inflammation-associated neurotoxicity. We especially welcome submissions focusing on neuroimaging techniques, including—but not limited to—perfusion MRI, functional MRI, vessel wall imaging, and amino acid PET. The early identification of these complications is essential for timely intervention and for maintaining patients’ quality of life.
Dr. Jasmina Boban
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuroimaging
- multimodal imaging
- chemotherapy
- immunotherapy
- chemotherapy-related cognitive dysfunction
- drug- related side effects and adverse reactions
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
